Dr. Robert Orlowski explains the basics of elotuzumab.
Watch Now
|
Dr. Robert Orlowski explains the first protein kinase inhibitor being studied for myeloma, from ASH 2011
Watch Now
|
Jack Aiello, 17-year survivor, attended the meeting and gives us his take on news that's significant for patients.
Watch Now
|